Innoviva (INVA) Change in Receivables (2010 - 2026)
Innoviva's (INVA) quarterly Change in Receivables came in at -$961000.0 in Q1 2026, up 74.16% YoY from -$551792.3 in Q1 2025, and down 109.83% on a QoQ basis from $9.8 million in Q3 2025.
Innoviva (INVA) Change in Receivables (2010 - 2026) Analysis & Trends
Innoviva (INVA) has 10 years of Change in Receivables data on file, last reported at -$961000.0 in Q1 2026.
- Quarterly Change in Receivables rose 74.16% year-over-year to -$961000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (down 62.16% YoY) and the FY2025 annual result came in at $14.6 million, up 145.44% from the prior year.
- Change in Receivables eased to -$961000.0 in Q1 2026, from $9.8 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $16.1 million in Q3 2024 to a low of -$3.7 million in Q1 2025.
- A 5-year average of $4.2 million and a median of $1.4 million in 2023 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 5980.47% — and 2025, when it sank 1080.63%.
- Tracing INVA's Change in Receivables over 5 years: stood at $867000.0 in 2022, then jumped by 55.82% to $1.4 million in 2023, then surged by 1091.12% to $16.1 million in 2024, then sank by 39.26% to $9.8 million in 2025, then plunged by 109.83% to -$961000.0 in 2026.
- The last three Change in Receivables figures came in at -$961000.0 (Q1 2026), $9.8 million (Q3 2025), and $4.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Innoviva | 1.54 Bn | 968.79 Mn | 90.62 Mn | 16.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.82 Mn |
| Jun 30, 2026 | 16.82 Mn |
| Mar 31, 2026 | -961,000.00 |
| Mar 31, 2026 | -961,000.00 |
| Sep 30, 2025 | 9.78 Mn |
| Sep 30, 2025 | 9.78 Mn |
| Jun 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 4.25 Mn |
| Mar 31, 2025 | -3.72 Mn |
| Mar 31, 2025 | -3.72 Mn |
| Sep 30, 2024 | 16.09 Mn |
| Sep 30, 2024 | 16.09 Mn |
| Jun 30, 2024 | 12.64 Mn |
| Jun 30, 2024 | 12.64 Mn |
| Mar 31, 2024 | -315,000.00 |
| Mar 31, 2024 | -315,000.00 |
| Sep 30, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Jun 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -215,000.00 |